HR 7693: To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

AI

Get a plain-English explanation of what this bill does, who it affects, and why it matters.

No bill text available yet

4%

Estimate based on legislative signals

See what factors are driving this score — cosponsor support, bipartisan backing, committee progress, and more.

Referred to the House Committee on Energy and Commerce.

To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.